Terkko Navigator / Leukemia

Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels

PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blasts

Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies

Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation

A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity

Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML

Spectrum and functional validation of PSMB5 mutations in multiple myeloma

Molecular remission as a therapeutic objective in acute promyelocytic leukemia

Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma

The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells

Correction: MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences

Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism

Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance

Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients

Time resolved quantitative phospho-tyrosine analysis reveals Bruton’s Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors

Modeling ASXL1 mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification

Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms

Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia

Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS

LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting

Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia

An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS

Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera

The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation

Diagnostic algorithm for lower-risk myelodysplastic syndromes

Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas

Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML

Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2

Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia

Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo

Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML

Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials

Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice

Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche

Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association

ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF

Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia

Multiple myeloma clonal evolution in homogeneously treated patients

Correction: A human bone marrow mesodermal-derived cell population with hemogenic potential

Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells

Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia

Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia

Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy

Response kinetics and factors predicting survival in core-binding factor leukemia

New drugs in AML: uses and abuses

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome

SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells